Arrowhead Pharmaceuticals Inc (ARWR)
ETFs that hold Arrowhead Pharmaceuticals Inc (ARWR)
Arrowhead Pharmaceuticals Inc is held by 14 ETFs tracked in our database. The largest position is held by XBI (1.05%), a sector fund. The remaining funds hold it at 0.55% or less. The largest holders are mostly sector and mid-cap funds.
ETFs holding Arrowhead Pharmaceuticals Inc (ARWR) in our database, ranked by portfolio weight.
Which ETFs hold Arrowhead Pharmaceuticals Inc (ARWR)?
The ETFs with the largest positions in Arrowhead Pharmaceuticals Inc (ARWR) are: SPDR S&P Biotech ETF (XBI, 1.05%); iShares Biotechnology ETF (IBB, 0.55%); SPDR S&P MidCap 400 ETF Trust (MDY, 0.27%); Vanguard Small-Cap Growth ETF (VBK, 0.25%); iShares Core S&P Mid-Cap ETF (IJH, 0.24%). The full list, ranked by weight, is in the table.
How many ETFs hold Arrowhead Pharmaceuticals Inc (ARWR)?
Arrowhead Pharmaceuticals Inc (ARWR) is held by 14 ETFs tracked in our database. The largest position is in XBI, where it makes up 1.05% of the fund's assets.
What does the ETF weight mean?
The weight is the share of a fund's assets invested in the stock. It shows how much passive index-fund ownership the stock has and where it carries the most influence. XBI holds Arrowhead Pharmaceuticals Inc (ARWR) at 1.05%, and the simple average weight across the 14 funds is 0.20%.